Last reviewed · How we verify

NCT02901665

Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes

Completed NA Last updated 4 April 2019
What this trial tests

NA trial testing FCC intervention in Family Relationship in 78 participants. Completed in 30 September 2018.

Timeline
1 September 2014
Primary endpoint
30 September 2018
30 September 2018

Quick facts

Lead sponsorAnn & Robert H Lurie Children's Hospital of Chicago
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment78
Start date1 September 2014
Primary completion30 September 2018
Estimated completion30 September 2018
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Who can join

Adults 1 Day to 3 Months, any sex, with Family Relationship or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is to compare parent and infant outcomes and unit outcomes pre and post a planned unit-wide intervention aimed at increasing parent presence in the Neonatal Intensive Care Unit (NICU). The FCC intervention will consist of communicating an expectation that all NICU parents be present at minimum 4 hours/day versus the current practice of telling families to "come as much as they can" that has resulted in inconsistent parent presence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ann & Robert H Lurie Children's Hospital of Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02901665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing